Douglas T. Fearon

Altered expression of complement receptors as a pathogenetic factor in systemic lupus erythematosus.

D. Fearon, J. Wilson, J. G. Wilson, 1984, Arthritis and rheumatism.

Classification of Current Anticancer Immunotherapies Classification of Current Anticancer Immunotherapies , Maha Ayyoub , Philipp Beckhove , Chiara Castelli

S. H. van der Burg, A. Palucka, M. Dhodapkar, 2022 .

Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2

D. Fearon, R. Carter, J. Ahearn, 1989, The Journal of experimental medicine.